中国组织工程研究 ›› 2017, Vol. 21 ›› Issue (22): 3567-3575.doi: 10.3969/j.issn.2095-4344.2017.22.021
• 生物材料综述 biomaterial review • 上一篇 下一篇
出版日期:
2017-08-08
发布日期:
2017-09-01
通讯作者:
张杭州,博士,副主任医师,中国医科大学附属第一医院骨科,辽宁省沈阳市 110000
作者简介:
王琳,男,1987年生,辽宁省沈阳市人,汉族, 2013年中国医科大学毕业,硕士,医师,主要从事运动医学与关节外科诊疗工作。
基金资助:
国家自然科学基金(81671811,81501857)
Online:
2017-08-08
Published:
2017-09-01
Contact:
Zhang Hang-zhou, M.D., Associate chief physician, Department of Orthopedics, the 1st Affiliated Hospital of China Medical University, Shenyang 110000, Liaoning Province, China
About author:
Wang Lin, Master, Physician, Department of Orthopedics, the 4th Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning Province, China
Supported by:
摘要:
文题释义: 纳米材料:是指在三维空间中至少有一维处于纳米尺寸(0.1-100.0 nm)或由它们作为基本单元构成的材料。 关节置换:是指用人工制造的关节代替疼痛且丧失关节功能的关节的方法,常用于髋及膝。制作人工关节的材料要求强度高、耐磨损、耐腐蚀、生物相容性好及无毒性。
中图分类号:
王 琳,陈丹莹,张治宇,张杭州. 纳米材料在关节置换内植物应用中的研究与特点[J]. 中国组织工程研究, 2017, 21(22): 3567-3575.
Wang Lin, Chen Dan-ying, Zhang Zhi-yu, Zhang Hang-zhou.
[1] Crowninshield RD, Rosenberg AG, Sporer SM. Changing demographics of patients with total joint replacement. Clin Orthop Relat Res. 2006;443:266-272. [2] Huang SL, He XJ, Wang KZ. Joint replacement in China: progress and challenges. Rheumatology (Oxford). 2012;51(9):1525-1526. [3] Jin SE, Jin WB, Hong S. Multi-scale Observation of biological interations of Nanocarriers from Nano to Macro. Microsc Res Tech. 2010;73(9):813-823. [4] Kam LC. Capturing the nanoscale complexity of cellular membranes in supported lipid bilayers. J Struct Biol. 2009;168(1): 3-10. [5] Zolnik BS, González-Fernández A, Sadrieh N, et al. Nanoparticles and the immune system. Endocrinology. 2010;151(2):458-465. [6] Tributsch H, Copf F, Copf P, et al. Nano-material aspects of shock absorption in bone joints. Open Biomed Eng J. 2010;4:257-262. [7] Qian T, Wang Y. Micro/nano-fabrication technologies for cell biology. Med Biol Eng Comput. 2010;48(10):1023-1032. [8] Meyer U, Büchter A, Wiesmann HP, et al. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mater. 2005;9:39-49. [9] Helmus MN, Gibbons DF, Cebon D. Biocompatibility: meeting a key functional requirement of next-generation medical devices. Toxicol Pathol. 2008;36(1):70-80. [10] Meirelles L, Melin L, Peltola T, et al. Effect of hydroxyapatite and titania nanostructures on early in vivo bone response. Clin Implant Dent Relat Res. 2008;10(4):245-254. [11] Meirelles L, Arvidsson A, Andersson M, et al. Nano hydroxyapatite structures influence early bone formation. J Biomed Mater Res A. 2008;87(2):299-307. [12] Meirelles L, Currie F, Jacobsson M, et al. The effect of chemical and nanotopographical modifications on the early stages of osseointegration. Int J Oral Maxillofac Implants. 2008;23(4): 641-647. [13] Traini T, Murmura G, Piattelli M, et al. Effect of nanoscale topography of titanium implants on bone vessel network, osteocytes, and mineral densities. J Periodontol. 2013;84(10): e40-e47. [14] Thierry B, Tabrizian M. Biocompatibility and biostability of metallic endovascular implants: state of the art and perspectives. J Endovasc Ther. 2003;10:807-824. [15] Reisetter AC, Stebounova LV, Baltrusaitis J, et al. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem. 2011;286(24):21844-21852. [16] Moghimi SM, Andersen AJ, Ahmadvand D, et al. Material properties in complement activation. Adv Drug Deliv Rev. 2011;63(12):1000-1007. [17] Salvador-Morales C, Flahaut E, Sim E, et al. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol. 2006;43(3):193-201. [18] Varu VN, Tsihlis ND, Kibbe MR. Basic science review: nitric oxide--releasing prosthetic materials. Vasc Endovascular Surg. 2009;43(2):121-131. [19] Jordan SW, Chaikof EL. Novel thromboresistant materials. J Vasc Surg. 2007;45:104-115. [20] Dike LE, Chen CS, Mrksich M, et al. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev Biol Anim. 1999;35(8):441-448. [21] Lacerda SH, Semberova J, Holada K, et al. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano. 2011;5(7):5808-5813. [22] Patlolla A, Knighten B, Tchounwou P. Multi-walled carbon nanotubes induce cytotoxicity, genotoxicity and apoptosis in normal human dermal fibroblast cells. Ethn Dis. 2010;20(1):S1-65-72. [23] Patlolla A, Patlolla B, Tchounwou P. Evaluation of cell viability, DNA damage, and cell death in normal human dermal fibroblast cells induced by functionalized multiwalled carbon nanotube. Mol Cell Biochem. 2010;338(1-2): 225-232. [24] Cavallo D, Fanizza C, Ursini CL, et al.Multi-walled carbon nanotubes induce cytotoxicity and genotoxicity in human lung epithelial cells. J Appl Toxicol. 2012;32(6):454-464. [25] Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-789. [26] Sutherland IW. The biofilm matrix-an immobilised but dynamic environment. Trends Microbiol. 2001;9:222-227. [27] Nichols WW. Biofilms, antibiotics and penetration. Rev Med Microbiol. 1991;2:177-181. [28] Anderi JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicilin and ciprofloxacin, Antimicrob. Agents Chemother. 2000;44:1818-1824. [29] Bagge N, Ciofu O, Skocgaard LT, et al. Rapid development in vitro and in vivo of resistance to ceftazidimein biofilm-growing Pseudomonas aeruginosa due to chromosomal B-lactamase. APMIS 2000;108: 589-600. [30] Stoodley P, Ehrlich GD, Sedghizadeh PP, et al. Orthopaedic biofilm infections. Curr Orthop Pract. 2011;22(6):558-563. [31] Azam A, Ahmed AS, Oves M, et al.Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains. Int J Nanomedicine. 2012;7:3527-3535. [32] Tsao N, Luh TY, Chou CK, et al. In vitro action of carboxyfullerene. J Antimicrob Chemother. 2002;49(4):641-649. [33] Ercan B, Taylor E, Alpaslan E, et al. Diameter of titanium nanotubes influences anti-bacterial efficacy Nanotechnology. 2011;22(29):295102. [34] Puckett SD, Taylor E, Raimondo T, et al. Therelationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials. 2010;31:706-713. [35] Popat KC, Eltgroth M, Latempa TJ, et al. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loadedtitania nanotubes. Biomaterials. 2007;28(32):4880-4888. [36] Zhang H, Sun Y, Tian A, et al. Improved antibacterial activity and biocompatibility on Gentamicin-loaded TiO2 nanotubes: in vivo and in vitro studies. Int J Nanomedicine. 2013;8:4379-4389. [37] Jia G, Wang H, Yan L, et al. Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multiwall nantube, and fullerene. Environ Sci Technol. 2005;39:1378-1383. [38] Sayes CM, Liang F, Hudson JL, et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett. 2006;161(2):135-142. [39] Bottini M, Bruckner S, Nika K, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett. 2006;160:121-126. [40] Feng B, Weng J, Yang BC, et al. Characterization of titanium surfaces with calcium and phosphate and osteoblast adhesion. Biomaterials. 2005;25:3421-3428. [41] Oh SH, Finõnes RR, Daraio C, et al. Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials. 2005;26(24):4938-4943. [42] Kim HM, Himeno T, Kawashita M, et al. Surface potential change in bioactive titanium metal during the process of apatite formation in simulated body fluid. J Biomed Mater Res. 2003;67A(4): 1305-1309. [43] Bueno Rde B, Adachi P, Castro-Raucci LM, et al. Oxidative nanopatterning of titanium surfaces promotes production and extracellular accumulation of osteopontin. Braz Dent J. 2011; 22(3):179-184. [44] Jimbo R, Sotres J, Johansson C, et al. The biological response to three different nanostructures applied on smooth implant surfaces. Clin Oral Implants Res. 2012;23(6):706-712. [45] Liu Q, Huang S, Matinlinna JP, et al. Insight into Biological Apatite: Physiochemical Properties and Preparation Approaches. Biomed Res Int. 2013;2013:929748. [46] Pommer A, Muhr G, David A. Hydroxyapatite-coated Schanz pins in external fixators used for distraction osteogenesis: a randomized, controlled trial. J Bone Joint Surg Am. 2002;84-A(7): 1162-1166. [47] Johnson I, Akari K, Liu H. Nanostructured hydroxyapatite/poly(lactic-co-glycolic acid) composite coatingfor controlling magnesium degradation in simulated body fluid. Nanotechnology. 2013;24(37):375103. [48] D'Elía NL, Gravina AN, Ruso JM, et al. Manipulating the bioactivity of hydroxyapatite nano-rods structured networks: effects on mineral coatingmorphology and growth kinetic. Biochim Biophys Acta. 2013;1830(11):5014-5026. [49] Antonov EN, Bagratashvili VN, Popov VK, et al. Biocompatibility of Laser-deposited Hydroxyapatite Coatings on Titanium and Polymer Implant Materials. J Biomed Opt. 1998;3(4):423-428. [50] Shinto Y, Uchida A, Korkusuz F, et al. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br. 1992;74(4):600-604. [51] Krisanapiboon A, Buranapanitkit B, Oungbho K. Biocompatability of hydroxyapatite composite as a local drug delivery system. J Orthop Surg (Hong Kong). 2006;14(3):315-318. |
[1] | 庄至坤, 吴荣凯, 林行会, 龚志兵, 张前进, 魏秋实, 张庆文, 吴昭克. 稳定增强型内衬髋关节系统在偏瘫老年股骨颈骨折全髋关节置换中的应用[J]. 中国组织工程研究, 2022, 26(9): 1429-1433. |
[2] | 张立创, 徐 浩, 马迎辉, 熊梦婷, 韩海慧, 鲍嘉敏, 翟伟韬, 梁倩倩. 免疫调控淋巴回流功能治疗类风湿关节炎的机制及前景[J]. 中国组织工程研究, 2022, 26(9): 1459-1466. |
[3] | 李志一, 贺鹏程, 边天月, 肖玉霞, 高 璐, 刘华胜. 铁死亡机制研究的文献计量学与可视化分析[J]. 中国组织工程研究, 2022, 26(8): 1202-1209. |
[4] | 黄 浩, 洪 嵩, 瓦庆德. 全膝关节置换过程中股骨假体旋转对髌股关节接触压影响的有限元分析[J]. 中国组织工程研究, 2022, 26(6): 848-852. |
[5] | 袁 景, 孙效虎, 陈 慧, 乔永杰, 王立新. 成人继发性膝外翻畸形股骨远端的数字化测量与分析[J]. 中国组织工程研究, 2022, 26(6): 881-885. |
[6] | 周建国, 刘世伟, 袁长红, 毕声荣, 杨国平, 胡伟全, 刘 辉, 钱 锐. 后交叉韧带保留型假体全膝关节置换治疗膝骨性关节炎合并膝外翻畸形[J]. 中国组织工程研究, 2022, 26(6): 892-897. |
[7] | 杨 峰, 赵 骞, 张世轩, 赵铁男, 冯 博. 雷帕霉素联合CD133抗体支架预防血管再狭窄的有效性和安全性[J]. 中国组织工程研究, 2022, 26(4): 579-584. |
[8] | 沈佳华, 付 勇. 基于石墨烯的纳米材料可否在干细胞领域应用[J]. 中国组织工程研究, 2022, 26(4): 604-609. |
[9] | 张 通, 蔡金池, 袁志发, 赵海燕, 韩兴文, 王文己. 基于透明质酸的复合水凝胶修复骨关节炎软骨损伤:应用与机制[J]. 中国组织工程研究, 2022, 26(4): 617-625. |
[10] | 黄诗博, 谢 辉, 王宗璞, 王韦丹, 覃开蓉, 赵德伟. 可降解高纯度镁金属骨钉固定修复发育性髋关节发育不良[J]. 中国组织工程研究, 2022, 26(4): 493-498. |
[11] | 王金子, 丁 海, 张 衡, 常文举, 刘奋斗. 不同透视角度下髋臼杯覆盖率:评估复杂类型髋关节发育不良全髋关节置换假体的位置[J]. 中国组织工程研究, 2022, 26(3): 350-353. |
[12] | 李 凯, 刘振东, 李小磊, 王静成. 后外侧入路全髋关节置换后假体反复性脱位的危险因素[J]. 中国组织工程研究, 2022, 26(3): 354-358. |
[13] | 王 冲, 张梅莹, 周 健, 劳克诚. 直接前方与后外侧入路进行全髋关节置换患者早期的步态变化[J]. 中国组织工程研究, 2022, 26(3): 359-364. |
[14] | 潘 浩, 赵慧慧, 王江静, 王 峰, 王 朋, 石秋玲, 郭 锦, 李 琳, 刘国强. 运动学对线与机械力学对线指导全膝关节置换后步态分析的比较[J]. 中国组织工程研究, 2022, 26(3): 365-370. |
[15] | 曲鹏飞, 王慧声, 李 锡. 初次全膝关节置换失血量与置换后低白蛋白血症、低钙血症的相关性[J]. 中国组织工程研究, 2022, 26(3): 376-382. |
关节置换已经是中国甚至世界上关节手术中最成功最常见的手术之一,随着关节置换手术的需求在不断地增多。与内置耗材相关的问题也在不断的增多,在本综述中,详细介绍了纳米材料相关的生物反应,和与材料相关的一些组织相容性问题,以及已经用于改善纳米结构材料组织相容性的方法。
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||